Atlas Trials

Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease

Clinical trial NCT03412513 · UNKNOWN

Trial details

NCT number
NCT03412513
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive BladderParkinson Disease
Start date
2017-07-17
Primary completion
2018-07-16
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.